Cardiology In The Time of COVID-19: Digital Medicine
The COVID-19 pandemic is forcing doctors and health care teams around the globe to adapt to a health care environment that is changing by the hour. Physicians and hospitals are shifting priorities to prepare for and accommodate severely ill patients. As the disease spreads and new evidence emerges, we must be able to adapt our facilities and identify the risk factors for the development of cardiac complications in patients with COVID-19.
In response to the evolving pandemic, the Texas Heart Institute (THI) is dedicating its education series, Innovative Technologies & Techniques, to providing information to those in the medical community who are taking care of cardiovascular patients with and without COVID-19. The special series, Cardiology in the Time of COVID-19, will include discussions of current COVID-19 and cardiovascular care literature and will provide an online educational forum for discussing emerging topics related to preparing for and taking care of all patients being treated for COVID-19.
In each episode, THI medical directors and leadership will interview experts in their respective fields to provide early perspectives on relevant topics. The initial topics of discussion will explore strategies to consider when preparing facilities and staff for case surge and innovative practices for overcoming social distancing challenges to providing cardiac care during this unprecedented time. Importantly, because best practices are in flux and are evolving as we learn more about how this virus manifests, we will continually update and make available these web-based vignettes, for the educational benefit of our global medical community.
In this episode, series host Drs. Zvonimir Krajcer and Eduardo Hernandez discuss the impact of COVID-19 on digital medicine with Dr. Tony Das, MD, Interventional Cardiologist and Medical Director of Cardiac Innovation and Digital Health at Baylor Heart Hospitals in Dallas, Texas and Dr. William E. “Billy” Cohn, Vice President for Johnson & Johnson Medical Devices Companies and the Executive Director of the Center for Device Innovation at the Texas Medical Center.